Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50-64 years

scientific article published on 01 February 2009

Burden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50-64 years is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1086/595842
P698PubMed publication ID19115970

P2093author name stringMichael E Greenberg
Kristin L Nichol
Edward Ehlinger
Sarah J D'Heilly
P433issue3
P304page(s)292-298
P577publication date2009-02-01
P1433published inClinical Infectious DiseasesQ5133764
P1476titleBurden of influenza-like illness and effectiveness of influenza vaccination among working adults aged 50-64 years
P478volume48

Reverse relations

cites work (P2860)
Q46955663A cross sectional survey to evaluate knowledge, attitudes and practices regarding seasonal influenza and influenza vaccination among diabetics in Pretoria, South Africa
Q35114177A historically-controlled Phase III study in adults to characterize the acceptability of a process change for manufacturing inactivated quadrivalent influenza vaccine.
Q30416502Antibodies against conserved antigens provide opportunities for reform in influenza vaccine design
Q52647635Applications of gold nanoparticles in virus detection.
Q37190911Comparison of the levels of immunogenicity and safety of Zostavax in adults 50 to 59 years old and in adults 60 years old or older
Q93050110EXamining the knowledge, Attitudes and experiences of Canadian seniors Towards influenza (the EXACT survey)
Q30391262Economics of employer-sponsored workplace vaccination to prevent pandemic and seasonal influenza
Q84281909Effect of influenza-like illness and other wintertime respiratory illnesses on worker productivity: The child and household influenza-illness and employee function (CHIEF) study
Q35213138Employee influenza vaccination in a large cancer center with high baseline compliance rates: comparison of carrot versus stick approaches
Q30425960Employer-incurred health care costs and productivity losses associated with influenza
Q64079250Evaluating costs and health consequences of sick leave strategies against pandemic and seasonal influenza in Norway using a dynamic model
Q35085753Frailty is associated with impairment of vaccine-induced antibody response and increase in post-vaccination influenza infection in community-dwelling older adults
Q26782188Frequency and impact of confounding by indication and healthy vaccinee bias in observational studies assessing influenza vaccine effectiveness: a systematic review
Q38354298Healthcare worker influenza immunization vaccinate or mask policy: strategies for cost effective implementation and subsequent reductions in staff absenteeism due to illness
Q36497877Illness Severity and Work Productivity Loss Among Working Adults With Medically Attended Acute Respiratory Illnesses: US Influenza Vaccine Effectiveness Network 2012-2013
Q50026937Immunogenicity and safety of the first indigenously developed Indian tetravalent influenza vaccine (split virion) in healthy adults ≥ 18 years of age: A randomized, multicenter, phase II / III clinical trial
Q34862926Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years
Q36175132Impact of a web-based personally controlled health management system on influenza vaccination and health services utilization rates: a randomized controlled trial
Q37778053Inactivated split-virion seasonal influenza vaccine (Fluarix): a review of its use in the prevention of seasonal influenza in adults and the elderly
Q90248934Increasing influenza and pneumococcal vaccine uptake in the elderly: study protocol for the multi-methods prospective intervention study Vaccination60
Q95591446Influenza
Q24169778Influenza vaccination among persons with work-related asthma
Q52565679Influenza vaccination in the elderly: Is a trial on mortality ethically acceptable?
Q30411822Influenza virus resistance to neuraminidase inhibitors: implications for treatment
Q51784414Influenza-like illness in healthcare personnel at a paediatric referral hospital: clinical picture and impact of the disease.
Q45351057Influenza-related health care utilization and productivity losses during seasons with and without a match between the seasonal and vaccine virus B lineage
Q36887912Intanza (®) 9 µg intradermal seasonal influenza vaccine for adults 18 to 59 years of age.
Q36623009Management of influenza-like illness by homeopathic and allopathic general practitioners in France during the 2009-2010 influenza season
Q82769007Mandatory influenza immunisation of health-care workers
Q90092646On field vaccine effectiveness in three periods of 2018/2019 influenza season in Emilia-Romagna Region
Q60266951Phase III, randomized controlled trial to evaluate lot consistency of a trivalent subunit egg-based influenza vaccine in adults
Q37937113Planning for influenza vaccination in health care workers: an Intervention Mapping approach
Q30419690Planning influenza vaccination programs: a cost benefit model
Q34214127Protocol for a randomised controlled trial examining the impact of a web-based personally controlled health management system on the uptake of influenza vaccination rates.
Q59201060Recommendation for Mandatory Influenza Immunization of All Health Care Personnel
Q44838844Safety and immunogenicity of a quadrivalent inactivated influenza vaccine compared to licensed trivalent inactivated influenza vaccines in adults.
Q33541763Safety, efficacy, and immunogenicity of an inactivated influenza vaccine in healthy adults: a randomized, placebo-controlled trial over two influenza seasons
Q64127981Seasonal influenza morbidity estimates obtained from telephone surveys, 2007
Q90621495Seasonal influenza vaccination: knowledge, attitude and practice in Varna, Bulgaria
Q42235495Seasonal influenza vaccine effectiveness against influenza in 2012-2013: a hospital-based case-control study in Lithuania
Q29249025The Healthy Workplace Project: Reduced Viral Exposure in an Office Setting
Q50132581The burden of influenza-like illness in the US workforce
Q37087121The post-infection outcomes of influenza and acute respiratory infection in patients above 50 years of age in Japan: an observational study
Q55381827The potential economic value of influenza vaccination for healthcare workers in The Netherlands.
Q87446238Universal paid leave increases influenza vaccinations among employees in the U.S.
Q37405121Vaccination against classical influenza in health-care workers: self-protection and patient protection

Search more.